Control of colorectal cancer needs to be tailored to its etiology. Tumor promotion mechanisms in colitisassociated colon cancer differ somewhat from the mechanisms involved in hereditary and sporadic colorectal cancer. Unlike sporadic or inherited tumors, some experimental models show that colitisassociated colon tumors do not require cyclooxygenase (COX) expression for progression, and nonsteroidal anti-inflammatory drugs (NSAIDs) which prevent sporadic or inherited colon cancer do not prevent colitis-associated colon cancer. We report that myeloperoxidase (MPO), an ancestor of the COX isoenzymes, is a determinant of colitis-associated colon tumors in Apc Min/ þ mice. During experimentally induced colitis, inhibition of MPO by resorcinol dampened colon tumor development. Conversely, in the bowels of Apc Min/ þ mice without colitis, resorcinol administration or 'knockout' of MPO gene coincided with a slight, but discernible increase in colon tumor incidence. Acrolein, a by-product of MPO catalysis, formed a covalent adduct with the phosphatase tensin homolog (PTEN) tumor suppressor and enhanced the activity of the Akt kinase proto-oncogene in vitro and in vivo. Thus, MPO may be an important determinant of diet and inflammation on colon cancer risk via its effect on endogenous exposure to oxidants and acrolein. We propose a hypothetical model to explain an apparent dichotomy between colon tumor occurrence and MPO inhibition in inflamed versus non-inflamed colons.
Introduction
Chronic ulcerative colitis is an independent risk factor for colorectal cancer [1, 2] . Consistent with epidemiological observations in humans, experimentally-induced colitis increases colon tumor progession in the Apc Min/ þ mouse, a model of intestinal cancer [3] [4] [5] [6] [7] . While the molecular pathways of inherited, sporadic and colitis-associated colon tumor progression overlap, they are not identical [8, 9] . Tumor formation in some mouse models of colitisassociated colon cancer does not require cyclooxygenase (COX) expression [10] . In a study using COX-1 and COX-2 'knockout' mice, investigators concluded that the mechanism of colorectal tumor promotion in colitis-associated cancer differs from the mechanism of tumor promotion for hereditary and sporadic colorectal cancer [10] . However, the exact role of prostaglandins in colitis associated colorectal cancer models varies with the model [11] . Additionally, the pharmacological rationale for colon cancer prevention with non-steroidal anti-inflammatory drugs (NSAIDs) does not apply to colitis-associated tumors [12, 13] . In fact, NSAIDs aggravate inflammation and malignant progression in rodent models of colitis-associated tumors [14] [15] [16] , albeit with some exceptions [17] . One NSAID, 5-aminosalicylic acid, can maintain remission of ulcerative colitis, which ought to prevent colitis-associated colon cancer. However, that hypothesis is unproven despite many attempts at validation [12, 18] . Myeloperoxidase (MPO), an ancestor of COX enzymes [19] , helps gut associated lymphoid tissue defend against harmful enteric microbes, while tolerating harmless commensal bacteria and dietary antigens. Because MPO activity correlates with the severity of experimentally induced colitis [20] and its expression is an Abbreviations: Apc, adenomatous polyposis coli; BME, β-mercaptoethanol; COX, cyclooxygenase; DTT, dithiothreitol; DSS, dextran sodium sulfate; ECL, enhanced chemiluminescence; EPO, eosinophil peroxidase; FBS, fetal bovine serum; HRP, horse radish peroxidase; MBTH, 3-methyl-2-benzothiazolinone hydrazone hydrochloride; MEM, modified Eagle's medium; MPO, myeloperoxidase; NSAIDs, nonsteroidal anti-inflammatory drugs; PBS, phosphate buffered saline; PI3, phosphatidylinositol; PTEN, phosphatase and tensin homolog on chromosome 10; PVDF, polyvinylidene difluoride; WT, wild type ☆ Financial support: NCI P30 CA42014 and the Kansas City University of Medicine and Biosciences.
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indicator of colon cancer risk [21] [22] this mechanism may contribute to complex effects of diet on inflammation and colon cancer risk.
Materials and methods

Reagents
The following were used: resorcinol, acrolein, L-threonine, hydrogen peroxide (H 2 O 2 ) and 3-methyl-2-benzothiazolinone hydrazone hydrochloride monohydrate (MBTH) (Sigma Aldrich, St. 
background were identified by PCR amplification of genomic DNA isolated from mouse tails using salt precipitation. All mice, kept in standard housing conditions, and fed 8656 Teklad sterilizable rodent diet (Harlan Laboratories, Denver, CO). Mice were sacrificed by CO 2 asphyxiation.
DSS induced colitis
At 8 weeks of age Apc Min/ þ or wild type mice were given drinking water containing 2.5% (w/v) DSS for 7 days. The occurrence and severity of colitis was measured by quantifying the MPO activity, a proxy for colitis, in the intestinal mucosa of mice [20] . Both peroxidase and chlorination activity were quantified, with chlorination being a more specific index of MPO activity. (50 μL) at 25°C. Plates were covered with tin foil to protect from ambient light. The fluorescence intensity of fluorescein formed by MPO activity in each sample was measured continuously using excitation at 485 nm and emission at 530 nm. MPO activity is proportional to the rate of change of fluorescence in the linear portion of the curve, typically around 30 min after starting the reaction. Reaction rates were calculated after correction using a negative control (boiled samples plus MPO inhibitor). MPO levels were calibrated using serially diluted (1:2) MPO standard solutions ranging from 0 to 200 ng/ml. When resorcinol was used as an inhibitor it was added simultaneously with the substrate co-factor solution.
Tumor studies
Apc Min/ þ mice were divided into four groups. Starting at 8 weeks of age two groups of Apc Min/ þ mice were treated with 2.5% (w/v) DSS for 7 days, while the remaining two groups were given water. The MPO inhibitor resorcinol (1.25 mg/kg) or saline vehicles (0.20 ml) were injected once daily, i.p., for the duration of the DSS treatment. Mice were allowed to mature a further 6 weeks before being sacrificed. In addition, two separate groups of Apc Min/ þ and Apc Min/ þ x MPO À / À double mutant mice were matured to the same age as above and sacrificed to compare the effect of pharmacological inhibition of MPO by resorcinol [23] versus a genetic 'knockout' of MPO in a non-colitis background.
Tissue harvesting and tumor assessment
The small intestine and colon were dissected longitudinally and washed with ice-cold PBS. They were then fixed for 4 h in 10% formalin in PBS, and stored in 70% ethanol at 4°C. The intestine and colons were stained with methylene blue, and then polyps and colon tumors were counted with the aid of a dissecting microscope. The counting studies were independently performed by two individuals who had no knowledge of the genotype and/or type of treatment used for each mouse. Colon tumors were photographed, the largest and smallest diameters were recorded, and tumor volumes were calculated according to the equation (volume (mm 3 )¼π/6 Â largest diameter Â smallest diameter 2 ). Tumor load was calculated by summing all measured tumor volumes in a mouse.
Generation of acrolein in situ by MPO
2-Hydroxy-propenal and acrolein (2-propenal) were generated by incubating 1.5 μg MPO (10 nM), 150 mM chloride and 200 μM L-threonine in 1.0 ml of 0.05 M phosphate buffer, pH 7.0, at 37°C [22] . The reaction was initiated by the addition of 200 μM H 2 O 2 .
For some experiments incubation times were varied, MPO was omitted, or the MPO inhibitor resorcinol (0-100 μM) was added. (370 mM) and incubated for 10 min at 25°C. The MBTH derivative was stable for at least 5 h.
Cell culture
HCT116 cells were grown in modified Eagle's medium (MEM) with 10% fetal bovine serum (FBS), 100 units of penicillin/streptomycin, 2 mM L-glutamine, and 1 mM pyruvate. MCF-7 cells were grown in MEM with 10% v/v FBS, 2 mM L-glutamine, 1.5 g/l NaHCO 3 , 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 0.01 mg/ml bovine insulin, and 0.01 mg/ml gentamicin.
MPO dependent modulation of PTEN-Akt signaling
HCT 116 and MCF-7 cells were grown to $ 80% confluency; culture media was removed and replaced with 2 ml of 0.05 M phosphate buffer, pH 7.0, MPO, chloride and threonine as detailed above. Acrolein formation was initiated with 200 μM H 2 O 2 before addition to cells. Cells were exposed to the reaction products at 37°C for intervals from 0 to 30 min. For some experiments MPO was omitted, or resorcinol (0-100 μM) was added to modulate MPO dependent generation of reactive aldehydes. A phosphatidylinositol-3-kinase (PI3-K) inhibitor, wortmannin, was used as a control to modulate Akt activation. Treated cells were lysed in 250 mM sucrose, 50 mM Tris pH 7.4, 5 mM MgCl 2 , 1 mM EGTA, 1 Â complete protease inhibitor, 2 mM NaF and 2 mM sodium orthovanadate. Lysates from treated cells (15 mg protein) were fractionated on SDS-10% PAGE and proteins were transferred to polyvinyldifluoride membranes for immunoblot analysis of Akt and phospho-(S473) Akt as described [24, 25] .
2.9. Detection of acrolein-PTEN adducts in colonocytes from inflamed and non-inflamed colons of mice
After treatment of Apc
Min/ þ mice with either vehicle or DSS, 7resorcinol, (Fig. 1A) colons were removed. Colon crypts, and the colonocytes within, were isolated as described [26] . Longitudinally dissected colons were incubated in PBS containing 3 mM EDTA and 50 μM DTT for 90 min at 4°C. The colons were then washed and vigorously shaken in ice-cold PBS 3-4 times to release intact colon crypts and wash away any leukocytes. Colon crypts and their colonocytes were enriched via centrifugation at 40g for 10 min at 4°C, and then reconstituted in ice-cold cell lysis buffer. Colon crypts were lysed in buffer B and their PTEN protein was isolated by immunoprecipitation. Briefly, lysates were pre-cleared by incubation with 2 μg of mouse IgG and 20 μl of protein G PLUS agarose at 4°C for 30 min and centrifuged at 1000g at 4°C for 5 min. Aliquots containing equivalent amounts of total cellular protein were immunoprecipitated using 1 μg of mouse monoclonal anti-PTEN by incubation at 4°C for 2 h. Immune complexes were precipitated by incubation with 20 μl of protein G PLUS agarose at 4°C overnight and collected by centrifugation. Immunoprecipitates were washed four times with lysis buffer B, resuspended in Laemmli buffer, separated on a 10% SDS-polyacrylamide gel, and transferred to PVDF membranes. After blocking with 5% powered milk in 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 0.1% Tween 20, acrolein-modified PTEN was detected with the monoclonal antibody mAb5F6 (1:5000 dilution) [27] followed by horseradish peroxidase-conjugated mouse anti-goat IgG (1:10,000 dilution) followed by detection with ECL Plus s . Blots were stripped using buffer containing 62.5 mM Tris-HCl, pH 6.7, 100 mM 2-mercaptoethanol, 2% SDS, at 55°C for 30 min, and reprobed with the rabbit polyclonal antibodies to PTEN and visualized with HRP-conjugated secondary antibody followed by ECL Plus s .
Western immunoblotting
Samples were dissolved in 50 ml of Laemmli loading buffer, 0.5% BME and heated at 95°C for 10 min. Samples (15-30 mg protein) were fractionated by SDS-PAGE and transferred to polyvinyldifluoride membranes. Membranes were blocked with 5% w/v nonfat dry milk in tris buffered saline with Tween 20, and then incubated for 16 h at 4°C with primary antibodies, followed by HRP-conjugated secondary antibody (1:5000). Antigen-antibody complexes were detected with Western Lightning ECL reagents. The intensity of chemiluminescent protein-antibody complexes was quantified with a Kodak Image Station 440. Bar graphs depict the mean 7standard error from densitometric analyses of separate experiments.
Statistical analysis
Data was analyzed using the Microsoft Excel statistical package. A two-tail homoscedastic or heteroscedastic unpaired Student's ttest was used. A p-value of less than 0.05 was considered statistically significant.
Results
Leukocyte MPO activity in DSS-induced colitis correlates with colon tumor occurrence in Apc
Min/ þ mice At 10-12 weeks after birth, Apc Min/ þ mice fed a standard diet and normal drinking water have intestinal polyps, but few or no colon tumors [28] . In our experiments 42% of Apc Min/ þ control mice were free of any colon tumors and the others had only 1.3 colon tumors per mouse (range 1-3 colon tumors/mouse). Apc Min/ þ mice exposed to 2.5% w/v DSS in drinking water have increased colon tumor occurrence [29] . In our protocol all mice developed colon tumors, secondary to their colitis (100% incidence). The colon tumor number rose 13-fold to a mean ¼17. 3 . In these same mice, resorcinol reduced the number of polyps in the small intestine, by 20%, but this was not statistically significant.
MPO activity in the non-inflamed gut of Apc
Min/ þ mice correlates inversely with colon tumors Apc Min/ þ mice fed a standard diet and normal drinking waterwith no DSS-had few or no colon tumors [ Fig. 2, upper panel] . Administration of resorcinol (1.25 mg/kg) to these mice was associated with a small but discernible increase in colon tumor incidence from 58% during vehicle treatment, to 85% during . We draw attention to the fact that fewer tumors occur in non-inflamed colons (Fig. 2 ), compared to inflamed colons (Fig. 1) . Results in Fig. 2 imply that resorcinol may have impeded any role that MPO has in anti-tumor host-defense processes under basal conditions in the colon of Apc Min/ þ mice. Alternatively, resorcinol, or its metabolites, in Apc Min/ þ mice may have been carcinogenic. To address this issue we examined colon tumor formation in Apc Min/ þ /MPO À / À mice fed a standard diet and normal drinking water. In these mice genetic 'knockout' of the MPO gene heightened colon tumor incidence and number to the same extent (85%) as pharmacological suppression of MPO by resorcinol [ Fig. 2 ]. Like resorcinol, 'knockout' of the MPO gene only altered tumor incidence and number, but not the tumor volume or tumor load in Apc Min/ þ mice in our protocol (p 40.05).
3.3. Acrolein, a by-product of threonine and MPO catalysis, forms an adduct with PTEN, thereby enhancing Akt kinase proto-oncogene signaling
Reactive lipid-enals and -enones generated by COX or lipoxygenase enzymes during inflammation can irreversibly modify the PTEN tumor suppressor, inactivate its inositol phosphatase activity, and thereby nullify its restraint of Akt proto-oncogene signaling [24, 25] . MPO can generate acrolein, a prototypical-enal carcinogen [30] , from hydroxyl-amino acids at sites of inflammation [22] [ Fig. 3A and B]. When HCT 116 or MCF 7 cells were exposed in situ to acrolein generated by MPO, threonine, hydrogen peroxide, and chloride ions, the cells accumulated higher amounts of phospho-Ser 473 Akt, an index of Akt kinase activation. The MPO inhibitor, resorcinol, suppressed the formation of cellular phospho-Ser
473
-Akt [ Fig. 3C ] to about the same extent as 0.5 μM wortmannin, an inhibitor of phosphatidylinositol-3-kinase. During DSS-induced colitis, inflammation may expose colonocytes of Apc Min/ þ mice to the processes depicted in Fig. 3 . Consistent with this mechanistic hypothesis, colon crypts isolated from inflamed bowels of Apc Min/ þ mice contained PTEN protein that was post-translationally modified by acrolein [ Fig. 4A ]. Formation of acrolein-PTEN adducts in colonocytes also corresponded with Akt kinase activation (increased phospho-Ser 473 -Akt levels) and with the MPO activity in the samples [ Fig. 4B ].
Discussion
Colon tumor occurrence correlates with high MPO activity found in DSS-inflamed colons of Apc Min/ þ mice. MPO can generate oxidants that cause DNA damage, and mutagenesis [30] ; it can also generate acrolein as an oxidative by-product from unsaturated fats, serine, or threonine [31] . Acrolein-protein adducts in colon tissue are associated with the transition from benign to malignant colon tumors in humans [32] ; however, little is known about the identity of proteins that form acrolein adducts, or their role in the etiology of colon tumor progression. In colonocytes isolated from Apc Min/ þ with inflamed colons we found that PTEN, a prominent intestinal tumor suppressor, formed a protein adduct with acrolein. PTEN modification coincided with Akt proto-oncogene activation in these colonocytes. Reactive nitrogen species also reportedly oxidize PTEN and disable its restraint of Akt kinase signaling [33] . Thus, MPO metabolites or by-products may augment colitis-associated colon tumor occurrence via genetic and energetic mechanisms [34] . Genetically, oxidants and acrolein have mutagenic potential [30, 35] [38] . Fig. 5 depicts a speculative model to explain the apparent dichotomy between tumor occurrence and inhibition of MPO activity in inflamed versus non-inflamed colons. A similar dichotomy exists in humans. On one hand, MPO protein levels correlate directly with colorectal cancer progression [21] , and colon tumors have elevated MPO activity compared to non-inflamed colonic mucosa [39, 40] . On the other hand, malignancies have been associated with human MPO deficiency and MPO deficient neutrophils fail to destroy malignant cells [41, 42] . Resorcinol causes irreversible, H 2 O 2 -dependent loss of peroxidase activity in various heme-containing peroxidases [43] , including both MPO and EPO. Strictly speaking, we cannot exclude a contribution from other granulocytes, such as eosinophils, in DSSinduced colitis in Apc Min þ mice. A role for eosinophil peroxidase (EPO) in DSS-induced colitis has been established using EPO 'knockout' mice (EPO À / À ) [23] . Environmental and genetic variation can modify mouse models of disease [44] [45] [46] [47] , consequently results with (EPO À / À ) mice on a 129/Ola/Hsd Â 129/SvJ background, do not extrapolate seamlessly to Apc Min/ þ mice on a C57Bl/6J background. Generally, the involvement of neutrophils in DSS colitis in C57/Bl6J mice including Apc Min/ þ mice is well established [3] [4] [5] [6] [7] . It should be stressed that the investigators studying the role of eosinophils in DSS colitis were, themselves, unable to exclude a contribution from neutrophils [23] . Consistent with gut's dual role as a digestive organ and a lymphoid organ, diet and inflammation can modify colon cancer risk in complex ways. To interpret these complexities Bruce et al. [34] have proposed an intriguing model that integrates two separate mechanisms: (1) disruption of cellular energetic signaling processes, leading to growth and proliferation; (2) focal loss of epithelial barriers, inflammation and oxidative stress, leading to proliferation and mutation. Our results lend support and refinement to this model. In evaluating cancer risk Swenberg et al. [48] and Wild [49] have championed a comprehensive approach which considers all exposure events -both exogenous and endogenous. This includes electrophilic molecules that are generated in living cells and organs through normal physiology, lifestyle, and nutrition. Our results suggest that MPO is an aspect of the 'exposome' [49] that deserves attention in the etiology and control of colorectal cancer [50] [51] [52] .
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